Literature DB >> 1752955

Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait.

A K Gupta1, K A Kirchner, R Nicholson, J G Adams, A N Schechter, C T Noguchi, M H Steinberg.   

Abstract

A defect in urine concentrating ability occurs in individuals with sickle cell trait (HbAS). This may result from intracellular polymerization of sickle hemoglobin (HbS) in erythrocytes, leading to microvascular occlusion, in the vasa recta of the renal medulla. To test the hypothesis that the severity of the concentrating defect is related to the percentage of sickle hemoglobin present in erythrocytes, urinary concentrating ability was examined after overnight water deprivation, and intranasal desmopressin acetate (dDAVP) in 27 individuals with HbAS. The HbAS individuals were separated into those who had a normal alpha-globin genotype (alpha alpha/alpha alpha), and those who were either heterozygous (-alpha/alpha alpha) or homozygous (-alpha/-alpha) for gene-deletion alpha-thalassemia, because alpha-thalassemia modulates the HbS concentration in HbAS. The urinary concentrating ability was less in the alpha alpha/alpha alpha genotype than in the -alpha/alpha alpha or -alpha/-alpha genotypes (P less than 0.05). After dDAVP, the urine osmolality was greater in patients with the -alpha/-alpha genotype than with the -alpha/alpha alpha genotype (882 +/- 37 vs. 672 +/- 38 mOsm/kg H2O) (P less than 0.05); patients with the -alpha/alpha alpha genotype had greater concentrating ability than individuals with a normal alpha-globin gene arrangement. There was an inverse linear correlation between urinary osmolality after dDAVP and the percentage HbS in all patients studied (r = -0.654; P less than 0.05). A linear correlation also existed for urine concentrating ability and the calculated polymerization tendencies for an oxygen saturation of 0.4 and O (r = -0.62 and 0.69, respectively). We conclude that the severity of hyposthenuria in HbAS is heterogeneous. It is determined by the amount of HbS polymer, that in turn is dependent upon the percentage HbS, which is itself related to the alpha-globin genotype.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752955      PMCID: PMC295777          DOI: 10.1172/JCI115521

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Sickling phenomenon produced by hypertonic solutions: a possible explanation for the hyposthenuria of sicklemia.

Authors:  P E PERILLIE; F H EPSTEIN
Journal:  J Clin Invest       Date:  1963-04       Impact factor: 14.808

Review 2.  Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology.

Authors:  R P Hebbel
Journal:  Blood       Date:  1991-01-15       Impact factor: 22.113

3.  Effect of polymerization tendency on haematological, rheological and clinical parameters in sickle cell anaemia.

Authors:  A J Keidan; M C Sowter; C S Johnson; C T Noguchi; A J Girling; S M Stevens; J Stuart
Journal:  Br J Haematol       Date:  1989-04       Impact factor: 6.998

4.  Different hematologic phenotypes are associated with the leftward (-alpha 4.2) and rightward (-alpha 3.7) alpha+-thalassemia deletions.

Authors:  D K Bowden; A V Hill; D R Higgs; S J Oppenheimer; D J Weatherall; J B Clegg
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

5.  A new sickling disorder resulting from interaction of the genes for haemoglobin S and alpha-thalassaemia.

Authors:  D J Weatherall; J B Clegg; J Blankson; J R McNeil
Journal:  Br J Haematol       Date:  1969-12       Impact factor: 6.998

Review 6.  Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene.

Authors:  M H Steinberg; S H Embury
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

7.  A new gene deletion in the alpha-like globin gene cluster as the molecular basis for the rare alpha-thalassemia-1(--/alpha alpha) in blacks: HbH disease in sickle cell trait.

Authors:  M H Steinberg; M B Coleman; J G Adams; R C Hartmann; H Saba; N P Anagnou
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

8.  Molecular basis for nondeletion alpha-thalassemia in American blacks. Alpha 2(116GAG----UAG).

Authors:  S A Liebhaber; M B Coleman; J G Adams; F E Cash; M H Steinberg
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

9.  Prevalence and molecular heterogeneity of alfa+ thalassemia in two tribal populations from Andhra Pradesh, India.

Authors:  R Fodde; M Losekoot; M H van den Broek; M Oldenburg; N Rashida; A Schreuder; J T Wijnen; P C Giordano; N V Nayudu; P M Khan
Journal:  Hum Genet       Date:  1988-10       Impact factor: 4.132

10.  Polymerization of sickle cell hemoglobin at arterial oxygen saturation impairs erythrocyte deformability.

Authors:  M A Green; C T Noguchi; A J Keidan; S S Marwah; J Stuart
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

View more
  30 in total

1.  Prospective study of sickle cell trait and venous thromboembolism incidence.

Authors:  A R Folsom; W Tang; N S Roetker; A V Kshirsagar; V K Derebail; P L Lutsey; R Naik; J S Pankow; M L Grove; S Basu; N S Key; M Cushman
Journal:  J Thromb Haemost       Date:  2014-12-11       Impact factor: 5.824

2.  Biomarkers for early detection of sickle nephropathy.

Authors:  Nambirajan Sundaram; Michael Bennett; Jamie Wilhelm; Mi-Ok Kim; George Atweh; Prasad Devarajan; Punam Malik
Journal:  Am J Hematol       Date:  2011-05-31       Impact factor: 10.047

3.  Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait.

Authors:  Marsha J Treadwell; Lakenya McClough; Elliott Vichinsky
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

Review 4.  Physiological responses of sickle cell trait carriers during exercise.

Authors:  Philippe Connes; Harvey Reid; Marie-Dominique Hardy-Dessources; Errol Morrison; Olivier Hue
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

5.  Impact of sickle cell trait on the thrombotic risk associated with non-O blood groups in northern Nigeria.

Authors:  Sagir G Ahmed; Modu B Kagu; Umma A Ibrahim; Audu A Bukar
Journal:  Blood Transfus       Date:  2015-05-27       Impact factor: 3.443

Review 6.  The current state of sickle cell trait: implications for reproductive and genetic counseling.

Authors:  Lydia H Pecker; Rakhi P Naik
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

7.  Congolese children with sickle cell trait may exhibit glomerular hyperfiltration: A case control study.

Authors:  Michel Ntetani Aloni; René Makwala Ngiyulu; Célestin Ndosimao Nsibu; Pépé Mfutu Ekulu; Jean Robert Makulo; Jean-Lambert Gini-Ehungu; Nazaire Mangani Nseka; François Bompeka Lepira
Journal:  J Clin Lab Anal       Date:  2017-01-19       Impact factor: 2.352

Review 8.  The current state of sickle cell trait: implications for reproductive and genetic counseling.

Authors:  Lydia H Pecker; Rakhi P Naik
Journal:  Blood       Date:  2018-11-29       Impact factor: 22.113

9.  Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG).

Authors:  Scott T Miller; Winfred C Wang; Rathi Iyer; Sohail Rana; Peter Lane; Russell E Ware; Daner Li; Renée C Rees
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

Review 10.  Sickle Cell Trait from a Metabolic, Renal, and Vascular Perspective: Linking History, Knowledge, and Health.

Authors:  Caroline K Thoreson; Michelle Y O'Connor; Madia Ricks; Stephanie T Chung; Anne E Sumner
Journal:  J Racial Ethn Health Disparities       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.